Company intelligence / Profile preview

Zochem

Dickson, Tennessee, United States

Ownership: Private
Employees: ~78
Development stage: Other

Overview

Zochem supplies high purity, USP- and FDA-compliant zinc oxide across multiple regulated markets; clinical results are not reported since zinc oxide is a mature excipient/API and ingredient, not a novel drug.

Therapeutic areas: Metabolic DisordersDermatologyOther
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Zochem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zochem.

Explore the full profile